Advanced New Therapeutics and Diagnostics in Retinal Diseases and Glaucoma

视网膜疾病和青光眼的先进新疗法和诊断

• 批准号: nhmrc : 458737
• 负责人: Prof Dao-Yi Yu
• 金额: $ 236.78万
• 依托单位: The University of Western Australia
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-01-01 至 2011-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/advanced-new-therapeutics-diseases-glaucoma/99384
• 关键词: Advanced; New; Therapeutics; Diagnostics; Retinal

This program proposal targets the most common blinding diseases in clinical ophthalmology. The applicant team includes research and clinical ophthalmologists and basic scientists. The team have an internationally established reputation in bringing basic science discoveries to the point where they can impact directly on clinical diagnosis and therapy. The proposed research includes new treatment therapies for diabetic retinopathy, age related macular degeneration, and retinal vascular diseases. A new diagnostic technique for glaucoma and new instrumentation for detecting areas of poor blood flow and oxygen supply in the eye are also to be developed. Past successes in our current program grant make us confident that we can produce clinically useful outcomes from this new proposal.

本项目针对临床眼科最常见的致盲性疾病。申请人团队包括研究和临床眼科医生和基础科学家。该团队在将基础科学发现带到可以直接影响临床诊断和治疗的程度方面享有国际声誉。拟议的研究包括糖尿病视网膜病变、年龄相关性黄斑变性和视网膜血管疾病的新治疗方法。还将开发一种新的青光眼诊断技术和新的仪器，用于检测眼睛中血液流动和氧气供应不良的区域。过去在我们目前的项目资助中取得的成功使我们相信，我们可以从这项新提案中产生临床有用的结果。